BACKGROUND: Diagnosis of acute myocardial infarction (AMI) according to the universal definition is based on ischemic symptoms, imaging findings and elevated myocardial necrosis markers, preferably cardiac troponin I/T with diagnostic threshold representing the 99th percentile of a reference population. It is not clearly defined if this should be an unselected population-based or a healthy cohort with respect to cardiac diseases. Aim of the current study was to describe the distribution of troponin I using a sensitive assay and to evaluate the impact of cardiac diseases and cardiovascular risk factors in apparently healthy individuals. METHODS: Troponin I was determined using a contemporary sensitive assay (TnI Ultra, Siemens) with 10% coefficient of variation (0.03 ng/mL) below the published 99th percentile (0.04 ng/mL) in 5000 participants (49.2% female) of the Gutenberg Health Study, a community-based, prospective, observational single-center cohort study. The calculated 99 th percentile cut-offs were tested in 1818 patients with suspected AMI. RESULTS:Troponin I concentration representing the 99th percentile of the overall study population was 0.04 ng/mL. Excluding individuals with prevalent cardiovascular disease lowers the 99th percentile to 0.034 ng/mL. Exclusion of individuals with traditional risk factors or elevated natriuretic peptide leads to further reduction with 0.029/0.028 ng/mL. These lower cut-offs detect more patients at risk in individuals with suspected AMI. Correlations of troponin I with age, gender and traditional risk factors were observed. CONCLUSIONS:Troponin I concentrations in apparently healthy individuals are dependent on prevalent cardiovascular diseases, traditional risk factors, gender and age. Application of corresponding cut-offs in diagnosis of AMI alters the group of patients potentially at risk.
RCT Entities:
BACKGROUND: Diagnosis of acute myocardial infarction (AMI) according to the universal definition is based on ischemic symptoms, imaging findings and elevated myocardial necrosis markers, preferably cardiac troponin I/T with diagnostic threshold representing the 99th percentile of a reference population. It is not clearly defined if this should be an unselected population-based or a healthy cohort with respect to cardiac diseases. Aim of the current study was to describe the distribution of troponin I using a sensitive assay and to evaluate the impact of cardiac diseases and cardiovascular risk factors in apparently healthy individuals. METHODS: Troponin I was determined using a contemporary sensitive assay (TnI Ultra, Siemens) with 10% coefficient of variation (0.03 ng/mL) below the published 99th percentile (0.04 ng/mL) in 5000 participants (49.2% female) of the Gutenberg Health Study, a community-based, prospective, observational single-center cohort study. The calculated 99 th percentile cut-offs were tested in 1818 patients with suspected AMI. RESULTS: Troponin I concentration representing the 99th percentile of the overall study population was 0.04 ng/mL. Excluding individuals with prevalent cardiovascular disease lowers the 99th percentile to 0.034 ng/mL. Exclusion of individuals with traditional risk factors or elevated natriuretic peptide leads to further reduction with 0.029/0.028 ng/mL. These lower cut-offs detect more patients at risk in individuals with suspected AMI. Correlations of troponin I with age, gender and traditional risk factors were observed. CONCLUSIONS: Troponin I concentrations in apparently healthy individuals are dependent on prevalent cardiovascular diseases, traditional risk factors, gender and age. Application of corresponding cut-offs in diagnosis of AMI alters the group of patients potentially at risk.
Authors: Gabriela Querejeta Roca; Susan Redline; Brian Claggett; Natalie Bello; Christie M Ballantyne; Scott D Solomon; Amil M Shah Journal: Circulation Date: 2015-08-27 Impact factor: 29.690
Authors: Christoph Sinning; Arne Kieback; Philipp S Wild; Renate B Schnabel; Francisco Ojeda; Sebastian Appelbaum; Tanja Zeller; Edith Lubos; Edzard Schwedhelm; Karl J Lackner; Eike S Debus; Thomas Munzel; Stefan Blankenberg; Christine Espinola-Klein Journal: Clin Res Cardiol Date: 2014-02-02 Impact factor: 5.460
Authors: M Odette Gore; Stephen L Seliger; Christopher R Defilippi; Vijay Nambi; Robert H Christenson; Ibrahim A Hashim; Ron C Hoogeveen; Colby R Ayers; Wensheng Sun; Darren K McGuire; Christie M Ballantyne; James A de Lemos Journal: J Am Coll Cardiol Date: 2014-02-12 Impact factor: 24.094
Authors: Karin Wildi; Maria Rubini Gimenez; Raphael Twerenbold; Tobias Reichlin; Cedric Jaeger; Amely Heinzelmann; Christiane Arnold; Berit Nelles; Sophie Druey; Philip Haaf; Petra Hillinger; Nicolas Schaerli; Philipp Kreutzinger; Yunus Tanglay; Thomas Herrmann; Zoraida Moreno Weidmann; Lian Krivoshei; Michael Freese; Claudia Stelzig; Christian Puelacher; Katharina Rentsch; Stefan Osswald; Christian Mueller Journal: Circulation Date: 2015-05-06 Impact factor: 29.690
Authors: Stergios Tzikas; Lars Palapies; Constantinos Bakogiannis; Tanja Zeller; Christoph Sinning; Stephan Baldus; Christoph Bickel; Vassilios Vassilikos; Karl J Lackner; Andreas Zeiher; Thomas Münzel; Stefan Blankenberg; Till Keller Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240